Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19, SARS-CoV2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04619290
What this trial is testing

Outpatient Treatment With CoVid-19 With Prexablu

Who this might be right for
Sars Cov 2
Hospital Reg. Lic. Adolfo Lopez Mateos 46
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Not applicableStudy completedNCT04905823
What this trial is testing

Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

Who this might be right for
Type 1 Diabetes
Paolo Fiorina, MD 600
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableStudy completedNCT04810117
What this trial is testing

Monitoring the IgG/IgM Antibodies in COVID-19 Patients

Who this might be right for
COVID-19 Infections
University of Sargodha 373
Not applicableStudy completedNCT05054218
What this trial is testing

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Who this might be right for
Covid19SARS-CoV2 Infection
H. Lee Moffitt Cancer Center and Research Institute 336
Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Early research (Phase 1)WithdrawnNCT04371640
What this trial is testing

Sirolimus in COVID-19 Phase 1

Who this might be right for
SARS-CoV-2Covid-19
Walter K. Kraft
Testing effectiveness (Phase 2)Study completedNCT04312997
What this trial is testing

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

Who this might be right for
COVID-19
Pulmotect, Inc. 101
Not applicableStudy completedNCT02788903
What this trial is testing

A Patient-Centered PaTH to Addressing Diabetes

Who this might be right for
ObesityDiabetesCovid19
Milton S. Hershey Medical Center 2,622,164
Not applicableStudy completedNCT04906850
What this trial is testing

Evaluation of the New Variant 501Y.V2 of COVID-19

Who this might be right for
Covid19
Centre Hospitalier Régional Metz-Thionville 250
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT05648110
What this trial is testing

Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 3,882
Not applicableUnknownNCT04479982
What this trial is testing

Microbial Infection and AMR in Hospitalized Patients With Covid 19

Who this might be right for
Covid19
Assiut University 70
Not applicableNot Yet RecruitingNCT05238623
What this trial is testing

Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19

Who this might be right for
COVID-19 PneumoniaPost-acute COVID-19 SyndromeElectric Impedance
Jan-Christoph Lewejohann 50
Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Not applicableUnknownNCT04624997
What this trial is testing

Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection

Who this might be right for
COVID-19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 1,000
Not applicableStudy completedNCT05562479
What this trial is testing

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

Who this might be right for
Ovarian ReserveSARS-CoV-2 InfectionBlastocyst
Novafem 428
Not applicableLooking for participantsNCT04573062
What this trial is testing

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Who this might be right for
Post-Coronavirus Disease 19
National Institute of Neurological Disorders and Stroke (NINDS) 1,590
Next Page